Searched for
PREGA NEWS
Mankind Pharma’s Rx for success: Aatmanirbhar push, affordable careMankind Pharma, guided by Ramesh and Rajeev Juneja, is a leading Indian pharmaceutical firm. The company focuses on mass-market drugs and h...- Mankind Pharma to acquire Bharat Serums from Advent International for Rs 13,630 crMankind Pharma announced its acquisition of Bharat Serums and Vaccines Limited (BSV) from Advent International for approximately Rs 13,630 ...
- Mankind Pharma is frontrunner in Bharat Serums bidMankind Pharma is in talks to acquire Bharat Serums & Vaccines Ltd., a biopharmaceutical company with brands like Manforce Condoms and Preg...
- Fundamental Radar: Three factors may drive 14% domestic sales CAGR for Mankind PharmaMankind also has the most well-rounded therapeutic mix among peers, with strong brands across therapies. Its top-25 brands are still priced...
- Mankind Pharma Q3 Results: Cons PAT soars 60% YoY on robust all-round growthMankind Pharma Q3: Domestic revenue grew 20% YoY to Rs 2,400 crore, while exports more than doubled to Rs 207 crore. The strong domestic re...
- ET Awards for Corporate Excellence: Rx Meerut: Mankind Pharma's bottom-up journey to the leader boardThe company has for the last five years been ranked number one in the number of prescriptions. Manforce condoms, oral contraceptives Prega ...
- Mankind Pharma Q4 Results: Net profit jumps 52% YoY to Rs 294 croreThe company reported net profit of Rs 193 crore during the corresponding period of the previous year. Revenue from Operations at Rs 2,053 c...
- Mankind Pharma Q4 Results: Cons PAT jumps 50% YoY to Rs 285 crore, sales up 19%For FY23, the company reported a 11% drop in consolidated net profit to Rs 1,282 crore, despite a 12.4% growth in revenue to Rs 8,749 crore.
- We continuously evolve and believe that every successful formula has an expiry date, says Mankind Pharma’s Rajeev JunejaMankind Pharma's IPO will open on April 25. Rajeev Juneja, VC & MD, shares the company's journey from starting with an initial capital of R...
- Mankind Pharma IPO to open for subscription on April 25The company has hired Kotak Investment Banking, Axis Capital, IIFL Securities, Jefferies and JP Morgan as book-running lead managers while ...
- Mankind Pharma files DRHP for Rs 5,500 crore IPOThe company’s initial public offering comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.The ...
- Mankind Pharma plans $1 billion IPO, hires bankersIn the proposed offer for sale, existing investors ChrysCapital will sell about 1% stake, Capital International will sell another 6% while ...
- Mankind Pharma inks distribution pact with BDR Pharmaceuticals for COVID drugUnder the alliance, BDR Pharma will be manufacturing and marketing the product under a royalty free, limited and non-exclusive voluntary li...
- Mankind Pharma launches COVID protection policy to support families of deceased employeesUnder the COVID Protection Policy, the company will contribute an amount equivalent to five years of the last drawn gross annual salary to ...
- Mankind Pharma signs Anushka Sharma as brand ambassador of Prega NewsThe two-month-long ad campaign will run across television channels, digital platforms, and outdoors including hoardings and branding at pro...
- Apax Partners, Carlyle front-runners for Mankind Pharma stake saleApax Partners & Carlyle have been shortlisted and are currently the front-runners for the proposed stake sale by Mankind Pharma, said two s...
- Mankind Pharma looking to sell 15 per cent stake; PE funds make a bee-lineMankind Pharma is looking to sell a 15% stake in the company and is eyeing a premium valuation of $500-$600 mn for the same.
- SpiceJet says excess baggage fee needed to keep fare lucrative"Until and unless we do that, we would not be able to provide lucrative fares," SpiceJet Chief Marketing Officer Debojo Maharshi said when ...
- Mankind Pharma setting up Rs 100 crore facility in RajasthanThe Delhi-based firm, which manufactures various over-the-counter products including condoms, said the new facility would produce bulk APIs.
- Warburg Pincus offers $250 million for 11 per cent stake in rival ChrysCapital’s Mankind PharmaChrysCapital, which purchased the stake in 2007 for $24 mn will earn a 9-fold return, striking one of the largest exits in pharma sector by...
Load More
